Goda Lab’s SHT-sEV therapy combines physics an
Author: Michael
New paper argues broad impact of GLP-1s supports
Repair Biotechnologies has announced the appointm
Life Time has launched its newest facility, Life
Company plots Phase 3 trial of drug that targets
Collaboration brings AI-driven insights and scie
New directory connects trusted longevity clinics
Vetek Association’s Ilia Stambler on why inves
Ahead of World Menopause Day, we explore what re
Bexorg has secured $23 million in a Series A fina